A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy

Back

EHRA Premium Access

A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy

Session: Cardiac resynchronisation therapy - conduction system pacing 1

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor D. Faccenda (Naples, IT)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Daniele Faccenda

University of Naples Federico II, Naples (Italy)

0 follower

7 more presentations in this session

Electrocardiographic predictors of haemodynamic benefit from biventricular pacing: the role of atrioventricular timing measures

Speaker: Doctor T. Chakraborty (London, GB) Doctor A. Arnold (London, GB)

CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial.

Speaker: Doctor J. Francisco Pascual (Barcelona, ES)

His bundle pacing implantation in octogenarian patients: a substudy of the PACE-CONDUCT trial

Speaker: Doctor D. Stangl (Fuerth, DE)

Temporal evolution of His bundle pacing thresholds: a sub-study of the PACE-CONDUCT trial

Speaker: Doctor V. Buia (Fuerth, DE)

Right ventricular systolic pressure is an independent risk factor of all-cause death and inappropriate therapies in patients with implanted CRT-D

Speaker: Doctor J. Machowicz (Zabrze, PL)

Access the full session

Cardiac resynchronisation therapy - conduction system pacing 1

Speakers: Doctor D. Faccenda, Doctor T. Chakraborty, Doctor A. Arnold, Doctor J. Francisco Pascual, Doctor D. Stangl...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources